Sonio SAS

Based in France, Sonio provides a SaaS ultrasound reporting platform tailored for OB-GYN practices, enhancing care quality through clinical AI solutions and streamlined workflows. Founded in 2020 and headquartered in Paris, France, Sonio SAS specializes in cloud-based ultrasound reporting software for women's health. The company was co-founded by Cecile Dubois, who also serves as the CEO, alongside Julien Stirnemann, Remi Besson, and Yves Ville. Sonio has successfully raised a total amount of EUR 86.

00 mn through 6 deals, with the most recent funding round being a Trade Sale on September 2, 2024, where Samsung Medison Co. , Ltd. acquired Sonio from various investors including Bpifrance and Elaia Partners. Sonio's primary offering is its cloud-based ultrasound reporting software designed specifically for OB-GYN practices.

The platform utilizes clinical AI capabilities, notably through its FDA 510(k) cleared module, Sonio Detect, to enhance workflow efficiency and ensure quality control in prenatal care. The software automatically populates report fields based on ultrasound findings, facilitating informed clinical decisions by verifying predefined quality criteria and exam completeness. Clients, including women’s health practitioners across multiple countries, benefit from streamlined operations through integrations with existing systems such as PACs, EHRs, and fax services. Sonio's technology is instrumental for ultrasound practitioners and clinical executives, with the product being utilized in the United States, European markets, and other regions where access to high-quality prenatal care is critical.

In the most recent year of 2024, Sonio generated revenue of EUR 767,177. 90, with an EBITDA amount of EUR -6,560,334. 40. Sonio operates on a subscription-based revenue model, where healthcare professionals subscribe to access its software and receive ongoing support and updates.

Their key products, including Sonio Detect and Sonio Pro, are central to this model, enhancing both operational efficiency and clinical outcomes for healthcare providers. Following the acquisition by Samsung Medison on September 2, 2024, for EUR 86. 00 mn, Sonio aims to leverage the resources and technology of its new parent company to enhance AI-driven imaging workflows. With this strategic acquisition, Sonio plans to expand into new markets and geographic regions, focusing on enhancing its product offerings.

The funding will be utilized to develop new products that align with Samsung’s vision in the medical imaging space, ensuring that Sonio's innovations continue to support healthcare providers in delivering quality prenatal care.